Ki-ras Oncogene and p53 Tumour Suppressor Gene Mutations in Colorectal Carcinomas from the European Saar-Luxembourg Region are Less Frequent than Predicted by the Classic Adenoma-Carcinoma Sequence Model

By Pauly M.   Schmitz M.   Kayser I.   Tureci O.   Lagoda P.   Seitz G.   Dicato M.  

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2265-2272

Elsevier

Access to resources Recommend Favorite

p53 Gene Mutations and p21 Protein Expression Induced Independently of p53, by TGF- and -rays in Squamous Cell Carcinoma Cells

By Yoneda K.   Yokoyama T.   Yamamoto T.   Hatabe T.   Osaki T.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 278-283

Elsevier

Access to resources Recommend Favorite

p53 Mutations in Carcinoma of the Esophagus and Gastroesophageal Junction

By Sengpiel C.   Konig I. R.   Rades D.   Noack F.   Duchrow M.   Schild S. E.   Ludwig D.   Homann N.  

Cancer Investigation, Vol. 27, Iss. 1, 2009-01 ,pp. : 96-104

Informa Healthcare

Access to resources Recommend Favorite

RAS, BRAF, and TP53 Gene Mutations in Taiwanese Colorectal Cancer Patients

By  

Onkologie, Vol. 36, Iss. 12, 2013-11 ,pp. : 719-724

Karger

Access to resources Recommend Favorite

Biological significance of promoter hypermethylation of p14/ARF gene: Relationships to p53 mutational status in Tunisian population with colorectal carcinoma

By Chaar Ines   Amara Sameh   Elamine Olfa   Khiari Mariem   Ounissi Donia   Khalfallah Taher   Ben hmida Abdelmajid   Mzabi Sabeh   Bouraoui Saadia  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1439-1449

Springer Publishing Company

Access to resources Recommend Favorite